The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management (Sixth Edition)

Voet, Martin A

ISBN 10: 1627347461 / ISBN 13: 9781627347464

Edité par Brown Walker Press, 2020

A propos de cet article

pp. 242. N° de réf. du vendeur 26377082218

Détails bibliographiques

Titre : The Generic Challenge: Understanding Patents...

Éditeur : Brown Walker Press

Date d'édition : 2020

Reliure : Couverture souple

Etat : New

A propos de ce titre

Synopsis :

This Sixth Edition of The Generic Challenge provides important new updates on current regulatory, legal and commercial issues affecting brand and generic pharmaceutical products, including new laws establishing generics for biologics, and changes brought about by the recently enacted America Invents Act. It explains clearly and understandably the roles of patents, FDA regulation of drugs and the Hatch Waxman Act in commercial drug development in light of generic challenges and how improvements in innovative drug products provide benefits to patients while extending the commercial lives of the drugs. There is simply no other book of its kind on this important subject.

À propos de l?auteur:

Martin A. Voet was formerly Senior Vice President and Chief Intellectual Property Counsel for a Fortune 500 pharmaceutical company with over 25 years of experience. He is currently Adjunct Professor at USD School of Law and consultant to the pharma industry. He has degrees in chemistry, business and law, coupled with practical experience in patenting pharmaceutical and biological products, litigating with generic companies and providing hands-on planning for pharmaceutical product Life-cycle Management.